ERBB2 and breast carcinoma: Evaluation of the distribution of breast cancer specimens with no Her2 expression (Her2-0) from those with any Her2 expression (Her2-E) in each IHC category based on the limit of detection (LOD) of the QDB method using 4B5 antibodies.